84 related articles for article (PubMed ID: 11554335)
1. Combinatorial chemistry in steroid receptor drug discovery.
Flygare JA; Sutherlin DP; Brown SD
Methods Mol Biol; 2001; 176():353-8. PubMed ID: 11554335
[No Abstract] [Full Text] [Related]
2. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
3. Simple and efficient production of (Z)-4-hydroxytamoxifen, a potent estrogen receptor modulator.
Yu DD; Forman BM
J Org Chem; 2003 Nov; 68(24):9489-91. PubMed ID: 14629178
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal steroid receptor modulators.
Hermkens PH; Kamp S; Lusher S; Veeneman GH
IDrugs; 2006 Jul; 9(7):488-94. PubMed ID: 16821162
[TBL] [Abstract][Full Text] [Related]
5. The molecular perspective: tamoxifen and the estrogen receptor.
Goodsell DS
Stem Cells; 2002; 20(3):267-8. PubMed ID: 12004085
[No Abstract] [Full Text] [Related]
6. An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and beta-chlorophenetole.
Shiina I; Sano Y; Nakata K; Suzuki M; Yokoyama T; Sasaki A; Orikasa T; Miyamoto T; Ikekita M; Nagahara Y; Hasome Y
Bioorg Med Chem; 2007 Dec; 15(24):7599-617. PubMed ID: 17904372
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft.
Govek SP; Bonnefous C; Julien JD; Nagasawa JY; Kahraman M; Lai AG; Douglas KL; Aparicio AM; Darimont BD; Grillot KL; Joseph JD; Kaufman JA; Lee KJ; Lu N; Moon MJ; Prudente RY; Sensintaffar J; Rix PJ; Hager JH; Smith ND
Bioorg Med Chem Lett; 2019 Feb; 29(3):367-372. PubMed ID: 30587451
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
[TBL] [Abstract][Full Text] [Related]
11. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
[TBL] [Abstract][Full Text] [Related]
13. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.
Chao EY; Collins JL; Gaillard S; Miller AB; Wang L; Orband-Miller LA; Nolte RT; McDonnell DP; Willson TM; Zuercher WJ
Bioorg Med Chem Lett; 2006 Feb; 16(4):821-4. PubMed ID: 16307879
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
Blizzard TA; DiNinno F; Morgan JD; Wu JY; Chen HY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Zhang Z; Hayes EC; DaSilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Aug; 14(15):3865-8. PubMed ID: 15225686
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator.
Shoda T; Okuhira K; Kato M; Demizu Y; Inoue H; Naito M; Kurihara M
Bioorg Med Chem Lett; 2014 Jan; 24(1):87-9. PubMed ID: 24332630
[TBL] [Abstract][Full Text] [Related]
19. Protein structure-based design, synthesis strategy and in vitro pharmacological characterization of estrogen receptor alpha and beta selective compounds.
Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Elger W; Fritzemeier KH
Ernst Schering Res Found Workshop; 2004; (46):47-62. PubMed ID: 15248504
[No Abstract] [Full Text] [Related]
20. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
Salum LB; Polikarpov I; Andricopulo AD
J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
